Drug Type siRNA |
Synonyms- |
Target |
Mechanism HLA-E inhibitors(major histocompatibility complex, class I, E inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Discovery | CN | 26 Feb 2024 |